MedTrace Logo

Evaluation of Auto Antibodies in Oral Sub Mucous Fibrosis

NCT03011086 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 70

Last updated 2017-12-19

No results posted yet for this study

Summary

The etiology of OSMF is considered to be multifactorial. However, Role of autoimmunity had been suggested as one of the factors but remains unproven.

The present study is undertaken to evaluate the presence of auto antibodies in OSMF patients to pave a way for new arena of treatment with the etiology of this persistent condition

Conditions

  • Oral Submucous Fibrosis

Sponsors & Collaborators

  • Panineeya Mahavidyalaya Institute of Dental Sciences & Research Centre

    lead OTHER

Principal Investigators

  • NALLAN CHAITANYA, MDS · ASSOCIATE PROFESSOR

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2017-11-30
Completion
2017-12-31

Countries

  • India

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03011086 on ClinicalTrials.gov